The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Aspirin results in decreased expression of ABCA1 mRNA Aspirin affects the expression of and affects the activity of ABCA1 protein; PPARA affects the reaction [Aspirin affects the expression of ABCA1 mRNA]; PPARA affects the reaction [Aspirin affects the expression of ABCA1 protein] Aspirin results in increased expression of ABCA1 mRNA; Aspirin results in increased expression of ABCA1 protein
Aspirin results in increased expression of ABCB1 mRNA; Aspirin results in increased expression of ABCB1 protein [Aspirin results in increased expression of ABCB1 protein] which results in decreased uptake of clopidogrel Aspirin results in increased activity of ABCB1 protein
Aspirin results in increased expression of ACACA protein modified form CES1 protein promotes the reaction [Aspirin results in increased expression of ACACA protein modified form]
Aspirin results in increased expression of AHR mRNA AHR mutant form inhibits the reaction [Aspirin results in increased activity of PON1 protein]; AHR mutant form inhibits the reaction [Aspirin results in increased expression of APOA1 mRNA]; AHR mutant form inhibits the reaction [Aspirin results in increased expression of PON1 mRNA]
[troglitazone co-treated with Aspirin] results in decreased expression of AKT1 protein; [troglitazone co-treated with Aspirin] results in decreased expression of AKT1 protein modified form; Aspirin results in decreased phosphorylation of and results in decreased activity of AKT1 protein Aspirin results in increased activity of AKT1 protein Aspirin results in increased expression of AKT1 mRNA
ALB protein binds to and affects the transport of Aspirin; Aspirin inhibits the reaction [Adenosine Diphosphate results in decreased secretion of ALB protein]; Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of ALB protein]; Aspirin inhibits the reaction [Warfarin binds to ALB protein]; Aspirin inhibits the reaction [zomepirac glucuronide binds to ALB protein]; Aspirin promotes the reaction [menadione epoxide analog binds to ALB protein] Aspirin results in decreased secretion of ALB protein
Aspirin results in increased activity of ANPEP protein Aspirin results in increased expression of ANPEP mRNA; Aspirin results in increased expression of ANPEP protein
AHR mutant form inhibits the reaction [Aspirin results in increased expression of APOA1 mRNA]; Aspirin promotes the reaction [APOA1 affects the transport of Cholesterol]; PPARA affects the reaction [Aspirin promotes the reaction [APOA1 affects the transport of Cholesterol]] Aspirin results in increased activity of APOA1 mRNA
APOE polymorphism affects the susceptibility to Aspirin Aspirin inhibits the reaction [APOE gene mutant form results in decreased susceptibility to Arachidonic Acid] Aspirin inhibits the reaction [APOE gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]
Aspirin inhibits the reaction [[Benzo(a)pyrene affects the expression of APP protein] which results in increased abundance of amyloid beta-protein (1-42)]
Aspirin promotes the reaction [Fluorouracil results in increased expression of BAX protein]; CASP8 affects the reaction [Aspirin results in increased localization of BAX protein]; Fluorouracil promotes the reaction [Aspirin results in increased expression of BAX protein] Aspirin inhibits the reaction [Cisplatin results in increased expression of BAX protein] Bee Venoms inhibits the reaction [Aspirin results in increased expression of BAX protein]; Ranitidine inhibits the reaction [Aspirin results in increased expression of BAX protein] Aspirin results in decreased expression of BAX mRNA; Aspirin results in decreased expression of BAX protein
Aspirin inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2 protein inhibits the reaction [Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]; Aspirin inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; Aspirin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] Aspirin results in decreased expression of BCL2 mRNA; Aspirin results in decreased expression of BCL2 protein Aspirin inhibits the reaction [Azoxymethane results in increased expression of BCL2 mRNA] Aspirin results in increased expression of BCL2 mRNA; Aspirin results in increased expression of BCL2 protein
Aspirin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BDNF mRNA alternative form]; Aspirin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BDNF mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BDNF protein]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased methylation of BDNF promoter alternative form]
[Aspirin co-treated with TNFSF10 protein] results in increased cleavage of BID protein; CASP8 affects the reaction [Aspirin results in increased cleavage of BID protein]
[Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein; Aspirin inhibits the reaction [E2F1 protein binds to BIRC5 promoter]; epoxomicin inhibits the reaction [Aspirin results in decreased expression of BIRC5 protein] Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] Aspirin results in increased expression of BIRC5 mRNA Aspirin results in decreased expression of BIRC5 mRNA; Aspirin results in decreased expression of BIRC5 protein
Aspirin promotes the reaction [NOS3 protein binds to CALM1 protein]; HDAC3 protein inhibits the reaction [Aspirin promotes the reaction [NOS3 protein binds to CALM1 protein]]
Aspirin results in increased activity of CASP3 protein Aspirin inhibits the reaction [Cisplatin results in increased expression of CASP3 protein] Bee Venoms inhibits the reaction [Aspirin results in increased expression of CASP3 mRNA]; Bee Venoms inhibits the reaction [Aspirin results in increased expression of CASP3 protein]; Ranitidine inhibits the reaction [Aspirin results in increased expression of CASP3 mRNA]; Ranitidine inhibits the reaction [Aspirin results in increased expression of CASP3 protein] Aspirin results in increased expression of CASP3 mRNA; Aspirin results in increased expression of CASP3 protein [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein; [troglitazone co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein; Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP3 protein]; Aspirin inhibits the reaction [Etoposide results in increased activity of CASP3 protein]; Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Aspirin inhibits the reaction [Methotrexate results in decreased expression of CASP3 protein]; Aspirin results in increased cleavage of and results in increased activity of CASP3 protein; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein]; CDKN1A mutant form inhibits the reaction [Aspirin inhibits the reaction [Etoposide results in increased activity of CASP3 protein]] Aspirin results in decreased expression of CASP3 mRNA
Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP6 protein]; Aspirin results in increased cleavage of and results in increased activity of CASP6 protein
[Aspirin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein; [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of CASP8 protein; Aspirin results in increased cleavage of and results in increased activity of CASP8 protein; CASP8 affects the reaction [Aspirin results in increased cleavage of BID protein]; CASP8 affects the reaction [Aspirin results in increased localization of BAX protein] Aspirin results in increased expression of CASP8 mRNA Aspirin results in increased activity of CASP8 protein
[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein; Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein]; Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein]; Aspirin results in increased cleavage of and results in increased activity of CASP9 protein; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein] Aspirin results in increased activity of CASP9 protein
Aspirin results in decreased activity of CAT; Aspirin results in decreased activity of CAT protein Carvedilol inhibits the reaction [Aspirin results in decreased activity of CAT protein] Aspirin results in increased expression of CAT protein
Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Aspirin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [TNF results in increased secretion of CCL2 protein] Aspirin inhibits the reaction [Oxaliplatin results in increased expression of CCL2 mRNA]
Aspirin inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; Aspirin inhibits the reaction [Streptozocin results in increased expression of CCN2 mRNA]
Aspirin inhibits the reaction [Smoke analog results in increased expression of CCND1 protein]; Aspirin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; CTNNB1 affects the reaction [Aspirin results in decreased expression of CCND1 protein] Aspirin results in decreased expression of CCND1 mRNA; Aspirin results in decreased expression of CCND1 protein Aspirin results in increased expression of CCND1 mRNA
Aspirin promotes the reaction [troglitazone results in decreased expression of CCND3 protein]; troglitazone promotes the reaction [Aspirin results in decreased expression of CCND3 protein] Aspirin results in decreased expression of CCND3 mRNA; Aspirin results in decreased expression of CCND3 protein
CCR3 gene SNP affects the susceptibility to Aspirin; CCR3 SNP affects the susceptibility to Aspirin Aspirin results in increased expression of CCR3 mRNA
Aspirin results in decreased expression of CD44 protein alternative form Aspirin results in decreased expression of CD44 mRNA CTNNB1 affects the reaction [Aspirin results in decreased expression of CD44 protein alternative form]
Aspirin results in decreased expression of CDK2 mRNA; Aspirin results in decreased expression of CDK2 protein troglitazone promotes the reaction [Aspirin results in decreased expression of CDK2 protein]
Aspirin inhibits the reaction [Camptothecin results in increased expression of CDKN1A protein]; Aspirin promotes the reaction [romidepsin results in increased expression of CDKN1A protein]; Aspirin results in increased expression of and results in increased phosphorylation of CDKN1A protein; CDKN1A mutant form inhibits the reaction [Aspirin inhibits the reaction [Etoposide results in increased activity of CASP3 protein]]; PTGS1 mutant form inhibits the reaction [Aspirin promotes the reaction [romidepsin results in increased expression of CDKN1A protein]]; wortmannin inhibits the reaction [Aspirin results in increased expression of CDKN1A protein] Aspirin results in decreased expression of CDKN1A mRNA Aspirin results in increased expression of CDKN1A mRNA; Aspirin results in increased expression of CDKN1A protein Aspirin affects the expression of CDKN1A protein Aspirin results in decreased activity of CDKN1A protein
CES1 protein promotes the reaction [Aspirin results in increased expression of ACACA protein modified form]; CES1 protein promotes the reaction [Aspirin results in increased expression of PRKAA1 protein modified form]
Aspirin results in increased expression of CFLAR mRNA Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]
Aspirin results in increased phosphorylation of CTNNB1 protein Aspirin results in decreased localization of CTNNB1 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein]; CTNNB1 affects the reaction [Aspirin results in decreased expression of CCND1 protein]; CTNNB1 affects the reaction [Aspirin results in decreased expression of CD44 protein alternative form]; CTNNB1 affects the reaction [Aspirin results in decreased expression of CMET protein]; CTNNB1 affects the reaction [Aspirin results in decreased expression of MYC protein]; Lithium Chloride inhibits the reaction [Aspirin results in increased phosphorylation of CTNNB1 protein]
Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 protein] Aspirin results in decreased expression of CX3CL1 mRNA; Aspirin results in decreased expression of CX3CL1 protein
Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of CXCL1 protein]; Aspirin promotes the reaction [IL1A results in increased expression of CXCL1 mRNA]
Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of CXCL1 protein]; Aspirin promotes the reaction [IL1A results in increased expression of CXCL1 mRNA]
Aspirin results in increased expression of CYSLTR1 mRNA Aspirin inhibits the reaction [IL4 results in increased expression of CYSLTR1 mRNA] CYSLTR1 gene SNP affects the susceptibility to Aspirin; CYSLTR1 SNP affects the susceptibility to Aspirin
Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT1 mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT1 protein]
Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A protein]
Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B protein]
[troglitazone co-treated with Aspirin] results in decreased expression of E2F1 protein; Aspirin inhibits the reaction [E2F1 protein binds to BIRC5 promoter] Aspirin results in decreased expression of E2F1 mRNA
Aspirin promotes the reaction [EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides]; EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]; EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]; EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]]; EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Prostaglandin D2]]
Aspirin results in decreased expression of ERBB2 mRNA; Aspirin results in decreased expression of ERBB2 protein Aspirin results in increased expression of ERBB2 mRNA
Aspirin affects the expression of FAS protein Aspirin inhibits the reaction [Methotrexate results in increased expression of FAS protein] Aspirin results in increased expression of FAS mRNA Aspirin inhibits the reaction [Azoxymethane results in increased expression of FAS mRNA]
FCER1A gene SNP affects the susceptibility to Aspirin; FCER1A polymorphism affects the susceptibility to Aspirin Aspirin inhibits the reaction [IL4 results in increased expression of FCER1A mRNA]
Aspirin results in decreased secretion of FGA protein Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of FGA protein]; Aspirin promotes the reaction [Adenosine Diphosphate results in increased secretion of FGA protein]
Aspirin inhibits the reaction [Adenosine Diphosphate results in decreased secretion of FGB protein]; Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of FGB protein] Aspirin results in decreased secretion of FGB protein
Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of FGG protein]; Aspirin promotes the reaction [Adenosine Diphosphate results in increased secretion of FGG protein]
Aspirin promotes the reaction [FOSL1 protein binds to PLAUR promoter] Aspirin results in decreased expression of FOSL1 mRNA; Aspirin results in decreased expression of FOSL1 protein Aspirin results in increased expression of FOSL1 mRNA
Aspirin results in decreased expression of GFAP mRNA; Aspirin results in decreased expression of GFAP protein Aspirin results in increased expression of GFAP mRNA
GP1BA SNP results in decreased susceptibility to Aspirin GP1BA polymorphism results in increased susceptibility to Aspirin GP1BA polymorphism affects the susceptibility to Aspirin
Aspirin results in decreased phosphorylation of GSK3B protein Aspirin results in increased phosphorylation of GSK3B protein Aspirin results in decreased activity of GSK3B protein
apple polyphenol extract inhibits the reaction [Aspirin results in increased expression of HBEGF mRNA]; apple polyphenol extract inhibits the reaction [Aspirin results in increased expression of HBEGF protein] Aspirin results in increased expression of HBEGF mRNA; Aspirin results in increased expression of HBEGF protein
HDAC3 inhibits the reaction [Aspirin results in increased acetylation of and results in increased activity of NOS3 protein]; HDAC3 protein inhibits the reaction [Aspirin promotes the reaction [NOS3 protein binds to CALM1 protein]]
Aspirin inhibits the reaction [HGF results in increased activity of MAPK1 protein]; Aspirin inhibits the reaction [HGF results in increased activity of MAPK3 protein]; Aspirin inhibits the reaction [HGF results in increased expression of MMP9]
Aspirin inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein]
Aspirin results in decreased expression of ICAM1 mRNA; Aspirin results in decreased expression of ICAM1 protein Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]; Celecoxib inhibits the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]]
Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein]]; Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein] Aspirin results in increased expression of IFNG protein fucoidan promotes the reaction [Aspirin results in increased expression of IFNG protein] Aspirin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA]
Aspirin results in decreased activity of IKBKB protein Aspirin results in decreased phosphorylation of IKBKB protein Aspirin results in decreased expression of IKBKB protein
IL10 polymorphism results in increased susceptibility to Aspirin fucoidan promotes the reaction [Aspirin results in increased expression of IL10 protein] IL10 polymorphism affects the susceptibility to Aspirin
Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein]]
Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein]]
[Aspirin co-treated with IL1A] results in increased expression of TNF mRNA; Aspirin promotes the reaction [IL1A results in increased expression of CXCL1 mRNA]; Aspirin promotes the reaction [IL1A results in increased expression of IL1B mRNA]; Aspirin promotes the reaction [IL1A results in increased expression of IL6 mRNA]; Aspirin promotes the reaction [IL1A results in increased expression of PTGS2 mRNA]; Aspirin promotes the reaction [IL1A results in increased expression of PTGS2 protein]; Aspirin promotes the reaction [IL1A results in increased phosphorylation of MAPK14 protein]; IL1A promotes the reaction [Aspirin results in increased expression of PTGS2 mRNA]; IL1A promotes the reaction [Aspirin results in increased expression of PTGS2 protein]; IL1A promotes the reaction [Aspirin results in increased phosphorylation of MAPK14 protein] Aspirin results in increased expression of IL1A mRNA
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid promotes the reaction [Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of Dinoprostone]]; Ascorbic Acid promotes the reaction [Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]]; Ascorbic Acid promotes the reaction [Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of Dinoprostone]]; Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]; Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]; Aspirin inhibits the reaction [IL1B results in increased activity of EDNRB]; Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of Dinoprostone]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Aspirin promotes the reaction [IL1A results in increased expression of IL1B mRNA]; Celecoxib inhibits the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]]; Celecoxib promotes the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]]; Naproxen promotes the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]]; rofecoxib promotes the reaction [Aspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Dinoprostone]] Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein]; Aspirin inhibits the reaction [Azoxymethane results in increased expression of IL1B mRNA]; Aspirin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL1B protein]; Aspirin promotes the reaction [Acetic Acid results in increased expression of IL1B protein]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Carvedilol inhibits the reaction [Aspirin results in increased expression of IL1B protein]; lipopolysaccharide, Helicobacter pylori inhibits the reaction [Aspirin results in increased expression of IL1B protein] Aspirin results in decreased expression of IL1B mRNA IL1B polymorphism affects the susceptibility to Aspirin Aspirin inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; Aspirin inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; Aspirin inhibits the reaction [Cisplatin results in increased expression of IL1B mRNA] Aspirin results in increased expression of IL1B mRNA
Aspirin inhibits the reaction [IL4 results in increased activity of STAT6 protein]; Aspirin inhibits the reaction [IL4 results in increased expression of CYSLTR1 mRNA]; Aspirin inhibits the reaction [IL4 results in increased expression of FCER1A mRNA]; Aspirin inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein]; Aspirin promotes the reaction [CEBPB protein binds to IL4 promoter polymorphism] Aspirin results in decreased secretion of IL4 protein Aspirin results in decreased expression of IL4 mRNA Aspirin results in increased expression of IL4 mRNA
Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Aspirin promotes the reaction [IL1A results in increased expression of IL6 mRNA]; Aspirin results in decreased expression of and results in decreased secretion of IL6 protein; IL6 protein inhibits the reaction [Aspirin results in decreased expression of STAT3 protein modified form] Aspirin results in increased expression of IL6 protein Aspirin inhibits the reaction [Oxaliplatin results in increased expression of IL6 mRNA]; Aspirin inhibits the reaction [Oxaliplatin results in increased expression of IL6 protein]; Carvedilol inhibits the reaction [Aspirin results in increased expression of IL6 protein]; fucoidan inhibits the reaction [Aspirin results in increased expression of IL6 protein] Aspirin inhibits the reaction [Cisplatin results in increased expression of IL6 mRNA]; Aspirin inhibits the reaction [Cisplatin results in increased expression of IL6 protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] Aspirin results in decreased expression of IL6 protein Aspirin results in decreased expression of IL6 mRNA
ITGA2 polymorphism results in decreased susceptibility to Aspirin ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel co-treated with Adenosine Diphosphate]; ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel co-treated with Epinephrine]; ITGA2 gene SNP affects the susceptibility to [Aspirin co-treated with clopidogrel]
Aspirin results in decreased expression of ITGA2B protein Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGA2B protein]; Aspirin results in decreased expression of [ITGA2B protein binds to ITGB2 protein]; Aspirin results in decreased expression of [ITGA2B protein binds to ITGB3 protein]; Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGA2B protein]]
Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGB3 protein]; Aspirin results in decreased expression of [ITGA2B protein binds to ITGB3 protein]; Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGB3 protein]]; ITGB3 polymorphism affects the reaction [Aspirin affects the cleavage of F2 protein] Aspirin results in increased expression of ITGB3 mRNA; Aspirin results in increased expression of ITGB3 protein ITGB3 gene polymorphism results in decreased susceptibility to Aspirin; ITGB3 polymorphism results in decreased susceptibility to Aspirin; ITGB3 results in decreased susceptibility to Aspirin ITGB3 gene polymorphism affects the susceptibility to Aspirin
Aspirin inhibits the reaction [Glucose results in increased expression of JUN protein]; Aspirin promotes the reaction [JUN protein binds to PLAUR promoter] Aspirin results in increased expression of JUN mRNA
[Aspirin results in decreased activity of LCT protein] which results in decreased transport of Glucose Aspirin results in increased activity of LCT; Aspirin results in increased activity of LCT protein
Aspirin inhibits the reaction [LDLR gene mutant form results in decreased susceptibility to Arachidonic Acid] Aspirin inhibits the reaction [LDLR gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]; Aspirin promotes the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]; Aspirin promotes the reaction [Cholesterol, LDL binds to LDLR protein]
LTC4S affects the susceptibility to Aspirin; LTC4S gene SNP affects the susceptibility to Aspirin; LTC4S polymorphism affects the susceptibility to Aspirin
Aspirin inhibits the reaction [HGF results in increased activity of MAPK1 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Aspirin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein Aspirin results in increased activity of MAPK1 protein Aspirin results in decreased expression of MAPK1 protein modified form
Aspirin promotes the reaction [IL1A results in increased phosphorylation of MAPK14 protein]; IL1A promotes the reaction [Aspirin results in increased phosphorylation of MAPK14 protein]
Aspirin inhibits the reaction [HGF results in increased activity of MAPK3 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Aspirin results in decreased phosphorylation of and results in decreased activity of MAPK3 protein Aspirin results in decreased expression of MAPK3 protein modified form Aspirin results in increased activity of MAPK3 protein
Aspirin results in decreased expression of MCL1 protein Aspirin results in increased degradation of and results in decreased expression of MCL1 protein
Aspirin results in decreased expression of CMET protein Aspirin results in increased expression of MET mRNA CTNNB1 affects the reaction [Aspirin results in decreased expression of CMET protein]
Aspirin results in increased expression of MMP13 mRNA [Aspirin co-treated with Carbon Tetrachloride] results in increased expression of and results in increased cleavage of MMP13 protein
Aspirin results in decreased expression of MMP2 [Aspirin co-treated with Carbon Tetrachloride] results in increased expression of MMP2 protein Aspirin results in decreased secretion of MMP2 protein Aspirin results in decreased expression of MMP2 mRNA
Aspirin inhibits the reaction [HGF results in increased expression of MMP9] Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Aspirin results in decreased secretion of MMP9 protein Aspirin results in decreased expression of MMP9 mRNA Aspirin results in decreased expression of MMP9; Aspirin results in decreased expression of MMP9 mRNA Aspirin results in decreased activity of MMP9 protein
Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Bee Venoms inhibits the reaction [Aspirin results in increased expression of MPO protein]; Ranitidine inhibits the reaction [Aspirin results in increased expression of MPO protein]
Aspirin results in decreased expression of MYC mRNA Aspirin results in decreased expression of MYC mRNA; Aspirin results in decreased expression of MYC protein Aspirin results in increased expression of MYC mRNA CTNNB1 affects the reaction [Aspirin results in decreased expression of MYC protein]
Aspirin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Aspirin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Aspirin promotes the reaction [NFKB1 protein binds to SAT1 promoter] Aspirin results in decreased expression of NFKB1 mRNA Aspirin results in decreased localization of NFKB1 protein Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein] [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]; Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]] Aspirin results in increased activity of NFKB1 protein
Aspirin inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein]; Aspirin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [TNF results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIA protein]; Aspirin results in decreased phosphorylation of and results in increased expression of NFKBIA protein Aspirin results in decreased expression of NFKBIA mRNA Aspirin results in decreased degradation of NFKBIA protein Aspirin results in increased expression of NFKBIA protein Aspirin results in increased degradation of NFKBIA protein
Aspirin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased degradation of NFKBIB protein]; Aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIB protein]
Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of NOS2 protein] [Aspirin results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; Carvedilol inhibits the reaction [Aspirin results in increased expression of NOS2 protein]
Aspirin inhibits the reaction [Everolimus results in decreased expression of NOS3 protein]; Aspirin inhibits the reaction [Paclitaxel results in decreased expression of NOS3 protein]; Aspirin inhibits the reaction [Sirolimus results in decreased expression of NOS3 protein]; Aspirin promotes the reaction [NOS3 protein binds to CALM1 protein]; Aspirin results in increased acetylation of and results in increased activity of NOS3 protein; HDAC3 inhibits the reaction [Aspirin results in increased acetylation of and results in increased activity of NOS3 protein]; HDAC3 protein inhibits the reaction [Aspirin promotes the reaction [NOS3 protein binds to CALM1 protein]]
Aspirin affects the expression of NPPB mRNA [carvedilol co-treated with temocapril hydrochloride co-treated with Spironolactone co-treated with Aspirin] affects the expression of NPPB protein Aspirin results in increased expression of NPPB mRNA
P2RY1 polymorphism results in decreased susceptibility to Aspirin; P2RY1 SNP results in decreased susceptibility to Aspirin P2RY1 affects the susceptibility to Aspirin
[Aspirin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; Aspirin inhibits the reaction [Deoxycholic Acid results in increased cleavage of PARP1 protein]; Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein]; Aspirin results in increased cleavage of and results in increased activity of PARP1 protein; BCL2 protein inhibits the reaction [Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; troglitazone promotes the reaction [Aspirin results in increased cleavage of PARP1 protein]
Aspirin promotes the reaction [FOSL1 protein binds to PLAUR promoter]; Aspirin promotes the reaction [H4C16 protein modified form binds to PLAUR promoter]; Aspirin promotes the reaction [JUN protein binds to PLAUR promoter] Aspirin affects the expression of PLAUR mRNA Aspirin results in increased expression of PLAUR mRNA; Aspirin results in increased expression of PLAUR protein
Aspirin results in increased expression of PMAIP1 mRNA; Aspirin results in increased expression of PMAIP1 protein PMAIP1 results in increased susceptibility to Aspirin
Aspirin results in increased expression of PON1 mRNA Aspirin results in increased activity of PON1 mRNA; Aspirin results in increased activity of PON1 protein AHR mutant form inhibits the reaction [Aspirin results in increased activity of PON1 protein]; AHR mutant form inhibits the reaction [Aspirin results in increased expression of PON1 mRNA]
Aspirin affects the activity of PPARA protein PPARA affects the reaction [Aspirin affects the expression of ABCA1 mRNA]; PPARA affects the reaction [Aspirin affects the expression of ABCA1 protein]; PPARA affects the reaction [Aspirin promotes the reaction [APOA1 affects the transport of Cholesterol]] Aspirin results in increased expression of PPARA mRNA Aspirin results in increased expression of PPARA; Aspirin results in increased expression of PPARA mRNA; Aspirin results in increased expression of PPARA protein Aspirin results in decreased expression of PPARA protein Aspirin results in decreased activity of PPARA protein
Aspirin results in decreased activity of PPARD protein Aspirin results in increased expression of PPARD mRNA Aspirin results in decreased expression of PPARD protein
Aspirin results in decreased activity of PPARG protein Aspirin results in decreased expression of PPARG mRNA Aspirin results in increased expression of PPARG mRNA Aspirin results in increased expression of PPARG; Aspirin results in increased expression of PPARG mRNA; Aspirin results in increased expression of PPARG protein Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein]
Aspirin results in increased expression of PRKAA1 protein modified form Aspirin inhibits the reaction [Cisplatin results in decreased expression of PRKAA1 protein] CES1 protein promotes the reaction [Aspirin results in increased expression of PRKAA1 protein modified form]
[Aspirin results in increased acetylation of PTGS1 protein] which results in decreased chemical synthesis of Thromboxane A2; Aspirin inhibits the reaction [[Arachidonic Acid results in increased activity of PTGS1 protein] which results in increased susceptibility to Methamphetamine]; Aspirin inhibits the reaction [Arachidonic Acid results in increased activity of PTGS1 protein]; Aspirin inhibits the reaction [PTGS1 protein results in increased susceptibility to Methamphetamine]; PTGS1 mutant form inhibits the reaction [Aspirin promotes the reaction [romidepsin results in increased expression of CDKN1A protein]] Aspirin affects the expression of PTGS1 protein PTGS1 polymorphism affects the susceptibility to Aspirin Aspirin analog results in decreased activity of PTGS1 protein; Aspirin results in decreased activity of PTGS1 protein Aspirin results in decreased expression of PTGS1 mRNA Aspirin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of PTGS1 protein]; PTGS1 results in decreased susceptibility to [Hydrochloric Acid co-treated with Aspirin] PTGS1 gene polymorphism results in decreased susceptibility to Aspirin; PTGS1 gene SNP results in decreased susceptibility to Aspirin
Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA]; Aspirin inhibits the reaction [[Arachidonic Acid results in increased activity of PTGS2 protein] which results in increased susceptibility to Methamphetamine]; Aspirin inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein]; Aspirin inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [PTGS2 protein results in increased susceptibility to Methamphetamine]; Aspirin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [TNF results in increased expression of PTGS2 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of PTGS2 protein]; Aspirin promotes the reaction [IL1A results in increased expression of PTGS2 mRNA]; Aspirin promotes the reaction [IL1A results in increased expression of PTGS2 protein]; IL1A promotes the reaction [Aspirin results in increased expression of PTGS2 mRNA]; IL1A promotes the reaction [Aspirin results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [Aspirin results in decreased degradation of PTGS2 mRNA]; SB 203580 inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA]; SB 203580 inhibits the reaction [Aspirin results in increased expression of PTGS2 protein] Aspirin results in decreased activity of PTGS2 protein; Aspirin results in decreased activity of PTGS2 protein mutant form Aspirin results in increased expression of PTGS2; Aspirin results in increased expression of PTGS2 mRNA; Aspirin results in increased expression of PTGS2 protein Aspirin results in decreased expression of PTGS2 protein [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA; [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; apple polyphenol extract inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA]; apple polyphenol extract inhibits the reaction [Aspirin results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Carvedilol inhibits the reaction [Aspirin results in increased expression of PTGS2 protein] [[Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone; [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA; [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 protein; Aspirin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; Aspirin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] PTGS2 gene SNP affects the susceptibility to Aspirin; PTGS2 SNP affects the susceptibility to Aspirin Aspirin results in decreased expression of PTGS2 mRNA; Aspirin results in decreased expression of PTGS2 protein
Aspirin inhibits the reaction [troglitazone results in decreased expression of RB1 protein modified form]; Aspirin promotes the reaction [troglitazone results in increased expression of RB1 protein]; troglitazone inhibits the reaction [Aspirin results in decreased expression of RB1 protein modified form]; troglitazone promotes the reaction [Aspirin results in increased expression of RB1 protein]
REG1A results in decreased susceptibility to Aspirin Aspirin results in increased expression of REG1A mRNA; Aspirin results in increased expression of REG1A protein
Aspirin inhibits the reaction [Glucose results in increased expression of RELA protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Aspirin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Aspirin inhibits the reaction [TNF protein results in increased activity of RELA protein]; Aspirin results in decreased localization of and results in decreased activity of RELA protein Aspirin results in decreased localization of RELA protein [telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of RELA protein]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein]; Aspirin inhibits the reaction [Streptozocin results in increased expression of RELA protein] [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein]; Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein] Aspirin results in increased localization of RELA protein
Aspirin promotes the reaction [NFKB1 protein binds to SAT1 promoter]; Aspirin results in increased expression of and results in increased activity of SAT1 protein Aspirin results in increased expression of SAT1 mRNA
Aspirin affects the expression of SCARB1 mRNA Aspirin results in increased expression of SCARB1 mRNA; Aspirin results in increased expression of SCARB1 protein Aspirin affects the expression of SCARB1 protein Aspirin results in decreased expression of SCARB1 mRNA [Aspirin co-treated with Fenofibrate] results in increased expression of SCARB1 protein; Aspirin inhibits the reaction [Niacin results in increased expression of SCARB1 mRNA]; Aspirin results in decreased expression of and results in decreased activity of SCARB1 protein; Aspirin results in increased expression of and results in increased activity of SCARB1 protein
Aspirin results in decreased expression of SELP protein Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of SELP protein]; Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of SELP protein]] Aspirin results in increased expression of SELP protein
Aspirin inhibits the reaction [Everolimus results in decreased expression of SIRT1 protein]; Aspirin inhibits the reaction [Paclitaxel results in decreased expression of SIRT1 protein]; Aspirin inhibits the reaction [Sirolimus results in decreased expression of SIRT1 protein]
Aspirin results in increased expression of SOCS2 mRNA butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [Aspirin results in increased expression of SOCS2 mRNA]; SOCS2 affects the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]
IL6 protein inhibits the reaction [Aspirin results in decreased expression of STAT3 protein modified form] Aspirin results in decreased phosphorylation of STAT3 protein Aspirin results in decreased expression of STAT3 mRNA; Aspirin results in decreased expression of STAT3 protein modified form
Aspirin inhibits the reaction [IL4 results in increased activity of STAT6 protein]; Aspirin inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein]
TBXA2R gene SNP affects the susceptibility to Aspirin; TBXA2R polymorphism affects the susceptibility to Aspirin TBXA2R SNP results in decreased susceptibility to Aspirin
TCF4 protein promotes the reaction [Aspirin results in increased susceptibility to TNFSF10 protein] Aspirin results in decreased activity of TCF4 protein
Aspirin results in decreased expression of TGFB1 mRNA Aspirin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; Aspirin inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA] TGFB1 promoter SNP results in increased susceptibility to Aspirin
Aspirin results in increased expression of THBS1 mRNA Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of THBS1 protein]
[Aspirin co-treated with IL1A] results in increased expression of TNF mRNA; Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Aspirin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Aspirin inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Aspirin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Aspirin inhibits the reaction [TNF protein results in increased activity of RELA protein]; Aspirin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Aspirin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [TNF results in increased degradation of NFKBIA protein]; Aspirin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 protein]; Aspirin inhibits the reaction [TNF results in increased expression of CXCL8 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of PTGS2 mRNA]; Aspirin inhibits the reaction [TNF results in increased expression of PTGS2 protein]; Aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIA protein]; Aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIB protein]; Aspirin inhibits the reaction [TNF results in increased secretion of CCL2 protein]; Aspirin inhibits the reaction [TNF results in increased secretion of CXCL8 protein]; Aspirin promotes the reaction [Salmonella Vaccines results in increased expression of TNF protein] Aspirin results in increased expression of TNF protein [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein]; Aspirin inhibits the reaction [Azoxymethane results in increased expression of TNF mRNA]; Aspirin inhibits the reaction [Oxaliplatin results in increased expression of TNF mRNA]; Aspirin inhibits the reaction [Oxaliplatin results in increased expression of TNF protein]; Aspirin inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Aspirin promotes the reaction [Acetic Acid results in increased expression of TNF protein]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Bee Venoms inhibits the reaction [Aspirin results in increased expression of TNF protein]; Carvedilol inhibits the reaction [Aspirin results in increased expression of TNF protein]; lipopolysaccharide, Helicobacter pylori inhibits the reaction [Aspirin results in increased expression of TNF protein]; Ranitidine inhibits the reaction [Aspirin results in increased expression of TNF protein] Aspirin results in decreased expression of TNF mRNA [Aspirin co-treated with Lipopolysaccharides] results in increased secretion of TNF protein; [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]; [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Aspirin inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF protein]; Aspirin inhibits the reaction [Cisplatin results in increased expression of TNF mRNA]; Aspirin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Aspirin inhibits the reaction [TNF protein results in increased abundance of Dinoprostone]; Aspirin inhibits the reaction [TNF protein results in increased secretion of Dinoprostone]; SOCS2 affects the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] Aspirin affects the secretion of TNF protein TNF gene SNP affects the susceptibility to Aspirin; TNF polymorphism affects the susceptibility to Aspirin
[Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein; [Aspirin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein; [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of BID protein; [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein; [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein; [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of CASP8 protein; Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2 protein inhibits the reaction [Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; TCF4 protein promotes the reaction [Aspirin results in increased susceptibility to TNFSF10 protein] Aspirin inhibits the reaction [Azoxymethane results in increased expression of TNFSF10 mRNA]
Aspirin results in increased acetylation of TP53 protein Aspirin inhibits the reaction [sodium bichromate results in increased expression of TP53 protein] Aspirin results in increased expression of TRP53 protein Aspirin results in increased expression of TP53 protein
Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA] Aspirin results in decreased expression of TYMP mRNA
Aspirin results in decreased expression of VEGFA Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]; Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA] Aspirin affects the expression of VEGFA mRNA Aspirin results in decreased expression of VEGFA mRNA nitroaspirin inhibits the reaction [Aspirin results in decreased expression of VEGFA]
Aspirin results in decreased expression of XIAP protein Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein]
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of ABCA1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in decreased expression of ABCA1 mRNA]
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of AKT1 protein] Chitosan results in decreased phosphorylation of AKT1 protein
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA]
ARB2A protein affects the reaction [Chitosan results in decreased expression of CPE protein]; ARB2A protein affects the reaction [Chitosan results in decreased expression of MMP9 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK1 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK3 protein] Chitosan results in increased expression of ARB2A mRNA
[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein [Rutin co-treated with Chitosan] inhibits the reaction [Cyclophosphamide results in increased expression of BAX mRNA]; Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of BAX protein]
[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]; [Rutin co-treated with Chitosan] inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA]; Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]
Chitosan metabolite inhibits the reaction [Copper results in increased activity of CASP3 protein] Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Chitosan inhibits the reaction [carbendazim results in increased expression of CASP3 protein]; Chitosan promotes the reaction [Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP3 mRNA]]
[Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; [Curcumin co-treated with Chitosan analog] inhibits the reaction [Arsenic results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; Chitosan inhibits the reaction [carbendazim results in decreased expression of CAT protein]; Chitosan inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein]
Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of CLEC7A mRNA] Chitosan results in decreased expression of CLEC7A mRNA
Chitosan results in decreased expression of CPE mRNA; Chitosan results in decreased expression of CPE protein ARB2A protein affects the reaction [Chitosan results in decreased expression of CPE protein]
Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]; Fish Oils promotes the reaction [Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]]
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA]
Chitosan results in increased expression of GCG mRNA SB 203580 inhibits the reaction [Chitosan results in increased expression of GCG mRNA]; SB 203580 inhibits the reaction [Chitosan results in increased secretion of GCG protein]
Chitosan analog results in increased expression of GPX1 mRNA [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; [Chitosan analog co-treated with Quercetin] results in increased expression of GPX1 mRNA; Chitosan analog inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]
[Chitosan metabolite results in decreased susceptibility to Copper] which results in increased expression of HMOX1 mRNA; [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased expression of HMOX1 protein Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 mRNA]; Chitosan inhibits the reaction [carbendazim results in decreased expression of HMOX1 mRNA]
Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] Chitosan results in increased secretion of IL10 protein
Chitosan results in increased secretion of IL6 protein Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of MAPK3 protein] ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK3 protein]
ARB2A protein affects the reaction [Chitosan results in decreased expression of MMP9 protein] Chitosan results in decreased expression of MMP9 mRNA; Chitosan results in decreased expression of MMP9 protein
[Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein Chitosan analog affects the localization of NFE2L2 protein [Rutin co-treated with Chitosan] inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 mRNA]; Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]; Chitosan inhibits the reaction [carbendazim results in decreased expression of NFE2L2 mRNA]; pyrazolanthrone inhibits the reaction [Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]]; SB 203580 inhibits the reaction [Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]]
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of RELA protein]; Chitosan promotes the reaction [Curcumin inhibits the reaction [fenpropathrin results in increased expression of RELA mRNA]]
[Chitosan analog co-treated with Quercetin] results in increased expression of SOD1 mRNA; Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of SOD1 mRNA] Chitosan analog results in increased expression of SOD1 mRNA
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of TLR2 mRNA] Chitosan results in decreased expression of TLR2 mRNA
Chitosan results in decreased expression of TLR4 mRNA Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of TLR4 mRNA]
Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Chitosan results in increased secretion of TNF protein
browse the term
